MONDAY, Sept. 12, 2022 (HealthDay News) — Though the risk appears small, a new review suggests that, in rare instances, monkeypox may trigger serious neurological complications, including seizures and brain inflammation. The finding is based on a look at 19 studies conducted in the United States, the United Kingdom andContinue Reading
MONDAY, Sept. 12, 2022 (HealthDay News) — Researchers think they’ve figured out why Parkinson’s disease causes a person’s limbs to become so stiff that at times they can feel frozen in place. Using a robotic chair equipped with sensors, a research team has linked the activation of leg muscles inContinue Reading
THURSDAY, Sept. 8, 2022 (HealthDay News) – In a rare second review, a U.S. Food and Drug Administration panel on Wednesday recommended approval for an experimental drug for ALS (amyotrophic lateral sclerosis). The FDA is not obligated to follow its advisors’ recommendations, though it usually does. Wednesday’s vote was 7-2Continue Reading
WEDNESDAY, Sept. 7, 2022 (HealthDay News) — Singer Justin Bieber said Tuesday that he will take a break from touring while he takes care of his health. Bieber has a condition known as Ramsay Hunt syndrome, which is rare type of viral infection. Caused by the chickenpox- and shingles-related varicella-zosterContinue Reading
WEDNESDAY, Sept. 7, 2022 (HealthDay News) — Patients suspected of having amyotrophic lateral sclerosis (ALS) may soon be able to get a diagnosis much more quickly, not wasting the precious time many have left, new research suggests. In 2020, a blood test for ALS based on microRNA (short segments ofContinue Reading
TUESDAY, Sept. 6, 2022 (HealthDay Now) — For Mary Christ, the idea that depression is a chemical imbalance in the brain has always felt true to her personal experience. A former educator, Christ, 57, has taken antidepressants for much of her adult life. She experienced bouts of anxiety and panicContinue Reading
TUESDAY, Sept. 6, 2022 (HealthDay News) – A U.S. Food and Drug Administration panel will once again consider approval for an experimental drug for ALS, a rare second review for a disease that has no cure. The same panel that will meet Wednesday voted last March not to approve theContinue Reading
THURSDAY, Sept. 1, 2022 (HealthDay News) — Men with Down syndrome may think and remember better when treated with a brain hormone normally associated with fertility, a new small-scale study suggests. Rhythmic drip doses of gonadotropin-releasing hormone (GnRH) improved thinking skills in nearly all of a small group of adultContinue Reading
THURSDAY, Sept. 1, 2022 (HealthDay News) — When the wildly popular TV show “This Is Us” wrapped up its final season this year, it did so with a storyline that showed one of the lead characters dealing with Alzheimer’s disease as her adult children disagreed over the type of careContinue Reading
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Long-term steroid use can reshape the structure of the brain, causing some parts to shrink and others to grow, a major new study reports. People taking steroids — even inhaled steroids — appear to have less intact white matter structure in their brainsContinue Reading